カテゴリー： Market Monitor Global, 世界, 医療/バイオ

肺炎球菌ワクチン接種の世界市場見通し2023年-2029年

◆英語タイトル：Pneumococcal Vaccination Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8569 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：76 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Pneumococcal Vaccination Market 調査レポートは次の情報を含め、グローバルにおけるの肺炎球菌ワクチン接種市場規模と予測を収録しています。・世界の肺炎球菌ワクチン接種市場：売上、2018年-2023年、2024年-2029年
・世界の肺炎球菌ワクチン接種市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の肺炎球菌ワクチン接種市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「PPSV 23」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

肺炎球菌ワクチン接種のグローバル主要企業は、Pfizer、 GSK、 MSD、 Sanofipasteur、 CDIBP、 WALVAX、 Sinovac、 Bio Kangtaiなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、肺炎球菌ワクチン接種のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の肺炎球菌ワクチン接種市場：タイプ別、2018年-2023年、2024年-2029年
世界の肺炎球菌ワクチン接種市場：タイプ別市場シェア、2022年
・PPSV 23、PCV 7/13、PCV 10

世界の肺炎球菌ワクチン接種市場：用途別、2018年-2023年、2024年-2029年
世界の肺炎球菌ワクチン接種市場：用途別市場シェア、2022年
・子供、大人

世界の肺炎球菌ワクチン接種市場：地域・国別、2018年-2023年、2024年-2029年
世界の肺炎球菌ワクチン接種市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における肺炎球菌ワクチン接種のグローバル売上、2018年-2023年
・主要企業における肺炎球菌ワクチン接種のグローバル売上シェア、2022年
・主要企業における肺炎球菌ワクチン接種のグローバル販売量、2018年-2023年
・主要企業における肺炎球菌ワクチン接種のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer、 GSK、 MSD、 Sanofipasteur、 CDIBP、 WALVAX、 Sinovac、 Bio Kangtai

*************************************************************

・調査・分析レポートの概要
肺炎球菌ワクチン接種市場の定義
市場セグメント
世界の肺炎球菌ワクチン接種市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の肺炎球菌ワクチン接種市場規模
世界の肺炎球菌ワクチン接種市場規模：2022年 VS 2029年
世界の肺炎球菌ワクチン接種市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの肺炎球菌ワクチン接種の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の肺炎球菌ワクチン接種製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：PPSV 23、PCV 7/13、PCV 10
肺炎球菌ワクチン接種のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：子供、大人
肺炎球菌ワクチン接種の用途別グローバル売上・予測

・地域別市場分析
地域別肺炎球菌ワクチン接種市場規模 2022年と2029年
地域別肺炎球菌ワクチン接種売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 GSK、 MSD、 Sanofipasteur、 CDIBP、 WALVAX、 Sinovac、 Bio Kangtai
...

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccination. This report contains market size and forecasts of Pneumococcal Vaccination in global, including the following market information:
Global Pneumococcal Vaccination Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pneumococcal Vaccination Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Pneumococcal Vaccination companies in 2022 (%)
The global Pneumococcal Vaccination market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
PPSV 23 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pneumococcal Vaccination include Pfizer, GSK, MSD, Sanofipasteur, CDIBP, WALVAX, Sinovac and Bio Kangtai, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pneumococcal Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pneumococcal Vaccination Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Pneumococcal Vaccination Market Segment Percentages, by Type, 2022 (%)
PPSV 23
PCV 7/13
PCV 10
Global Pneumococcal Vaccination Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Pneumococcal Vaccination Market Segment Percentages, by Application, 2022 (%)
Child
Adult
Global Pneumococcal Vaccination Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Pneumococcal Vaccination Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pneumococcal Vaccination revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pneumococcal Vaccination revenues share in global market, 2022 (%)
Key companies Pneumococcal Vaccination sales in global market, 2018-2023 (Estimated), (Units)
Key companies Pneumococcal Vaccination sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
WALVAX
Sinovac
Bio Kangtai
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pneumococcal Vaccination, market overview.
Chapter 2: Global Pneumococcal Vaccination market size in revenue and volume.
Chapter 3: Detailed analysis of Pneumococcal Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pneumococcal Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pneumococcal Vaccination capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Pneumococcal Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pneumococcal Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pneumococcal Vaccination Overall Market Size
2.1 Global Pneumococcal Vaccination Market Size: 2022 VS 2029
2.2 Global Pneumococcal Vaccination Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pneumococcal Vaccination Sales: 2018-2029
3 Company Landscape
3.1 Top Pneumococcal Vaccination Players in Global Market
3.2 Top Global Pneumococcal Vaccination Companies Ranked by Revenue
3.3 Global Pneumococcal Vaccination Revenue by Companies
3.4 Global Pneumococcal Vaccination Sales by Companies
3.5 Global Pneumococcal Vaccination Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pneumococcal Vaccination Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pneumococcal Vaccination Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pneumococcal Vaccination Players in Global Market
3.8.1 List of Global Tier 1 Pneumococcal Vaccination Companies
3.8.2 List of Global Tier 2 and Tier 3 Pneumococcal Vaccination Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pneumococcal Vaccination Market Size Markets, 2022 & 2029
4.1.2 PPSV 23
4.1.3 PCV 7/13
4.1.4 PCV 10
4.2 By Type – Global Pneumococcal Vaccination Revenue & Forecasts
4.2.1 By Type – Global Pneumococcal Vaccination Revenue, 2018-2023
4.2.2 By Type – Global Pneumococcal Vaccination Revenue, 2024-2029
4.2.3 By Type – Global Pneumococcal Vaccination Revenue Market Share, 2018-2029
4.3 By Type – Global Pneumococcal Vaccination Sales & Forecasts
4.3.1 By Type – Global Pneumococcal Vaccination Sales, 2018-2023
4.3.2 By Type – Global Pneumococcal Vaccination Sales, 2024-2029
4.3.3 By Type – Global Pneumococcal Vaccination Sales Market Share, 2018-2029
4.4 By Type – Global Pneumococcal Vaccination Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pneumococcal Vaccination Market Size, 2022 & 2029
5.1.2 Child
5.1.3 Adult
5.2 By Application – Global Pneumococcal Vaccination Revenue & Forecasts
5.2.1 By Application – Global Pneumococcal Vaccination Revenue, 2018-2023
5.2.2 By Application – Global Pneumococcal Vaccination Revenue, 2024-2029
5.2.3 By Application – Global Pneumococcal Vaccination Revenue Market Share, 2018-2029
5.3 By Application – Global Pneumococcal Vaccination Sales & Forecasts
5.3.1 By Application – Global Pneumococcal Vaccination Sales, 2018-2023
5.3.2 By Application – Global Pneumococcal Vaccination Sales, 2024-2029
5.3.3 By Application – Global Pneumococcal Vaccination Sales Market Share, 2018-2029
5.4 By Application – Global Pneumococcal Vaccination Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pneumococcal Vaccination Market Size, 2022 & 2029
6.2 By Region – Global Pneumococcal Vaccination Revenue & Forecasts
6.2.1 By Region – Global Pneumococcal Vaccination Revenue, 2018-2023
6.2.2 By Region – Global Pneumococcal Vaccination Revenue, 2024-2029
6.2.3 By Region – Global Pneumococcal Vaccination Revenue Market Share, 2018-2029
6.3 By Region – Global Pneumococcal Vaccination Sales & Forecasts
6.3.1 By Region – Global Pneumococcal Vaccination Sales, 2018-2023
6.3.2 By Region – Global Pneumococcal Vaccination Sales, 2024-2029
6.3.3 By Region – Global Pneumococcal Vaccination Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pneumococcal Vaccination Revenue, 2018-2029
6.4.2 By Country – North America Pneumococcal Vaccination Sales, 2018-2029
6.4.3 US Pneumococcal Vaccination Market Size, 2018-2029
6.4.4 Canada Pneumococcal Vaccination Market Size, 2018-2029
6.4.5 Mexico Pneumococcal Vaccination Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pneumococcal Vaccination Revenue, 2018-2029
6.5.2 By Country – Europe Pneumococcal Vaccination Sales, 2018-2029
6.5.3 Germany Pneumococcal Vaccination Market Size, 2018-2029
6.5.4 France Pneumococcal Vaccination Market Size, 2018-2029
6.5.5 U.K. Pneumococcal Vaccination Market Size, 2018-2029
6.5.6 Italy Pneumococcal Vaccination Market Size, 2018-2029
6.5.7 Russia Pneumococcal Vaccination Market Size, 2018-2029
6.5.8 Nordic Countries Pneumococcal Vaccination Market Size, 2018-2029
6.5.9 Benelux Pneumococcal Vaccination Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pneumococcal Vaccination Revenue, 2018-2029
6.6.2 By Region – Asia Pneumococcal Vaccination Sales, 2018-2029
6.6.3 China Pneumococcal Vaccination Market Size, 2018-2029
6.6.4 Japan Pneumococcal Vaccination Market Size, 2018-2029
6.6.5 South Korea Pneumococcal Vaccination Market Size, 2018-2029
6.6.6 Southeast Asia Pneumococcal Vaccination Market Size, 2018-2029
6.6.7 India Pneumococcal Vaccination Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pneumococcal Vaccination Revenue, 2018-2029
6.7.2 By Country – South America Pneumococcal Vaccination Sales, 2018-2029
6.7.3 Brazil Pneumococcal Vaccination Market Size, 2018-2029
6.7.4 Argentina Pneumococcal Vaccination Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pneumococcal Vaccination Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pneumococcal Vaccination Sales, 2018-2029
6.8.3 Turkey Pneumococcal Vaccination Market Size, 2018-2029
6.8.4 Israel Pneumococcal Vaccination Market Size, 2018-2029
6.8.5 Saudi Arabia Pneumococcal Vaccination Market Size, 2018-2029
6.8.6 UAE Pneumococcal Vaccination Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Pneumococcal Vaccination Major Product Offerings
7.1.4 Pfizer Pneumococcal Vaccination Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Pneumococcal Vaccination Major Product Offerings
7.2.4 GSK Pneumococcal Vaccination Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 MSD
7.3.1 MSD Company Summary
7.3.2 MSD Business Overview
7.3.3 MSD Pneumococcal Vaccination Major Product Offerings
7.3.4 MSD Pneumococcal Vaccination Sales and Revenue in Global (2018-2023)
7.3.5 MSD Key News & Latest Developments
7.4 Sanofipasteur
7.4.1 Sanofipasteur Company Summary
7.4.2 Sanofipasteur Business Overview
7.4.3 Sanofipasteur Pneumococcal Vaccination Major Product Offerings
7.4.4 Sanofipasteur Pneumococcal Vaccination Sales and Revenue in Global (2018-2023)
7.4.5 Sanofipasteur Key News & Latest Developments
7.5 CDIBP
7.5.1 CDIBP Company Summary
7.5.2 CDIBP Business Overview
7.5.3 CDIBP Pneumococcal Vaccination Major Product Offerings
7.5.4 CDIBP Pneumococcal Vaccination Sales and Revenue in Global (2018-2023)
7.5.5 CDIBP Key News & Latest Developments
7.6 WALVAX
7.6.1 WALVAX Company Summary
7.6.2 WALVAX Business Overview
7.6.3 WALVAX Pneumococcal Vaccination Major Product Offerings
7.6.4 WALVAX Pneumococcal Vaccination Sales and Revenue in Global (2018-2023)
7.6.5 WALVAX Key News & Latest Developments
7.7 Sinovac
7.7.1 Sinovac Company Summary
7.7.2 Sinovac Business Overview
7.7.3 Sinovac Pneumococcal Vaccination Major Product Offerings
7.7.4 Sinovac Pneumococcal Vaccination Sales and Revenue in Global (2018-2023)
7.7.5 Sinovac Key News & Latest Developments
7.8 Bio Kangtai
7.8.1 Bio Kangtai Company Summary
7.8.2 Bio Kangtai Business Overview
7.8.3 Bio Kangtai Pneumococcal Vaccination Major Product Offerings
7.8.4 Bio Kangtai Pneumococcal Vaccination Sales and Revenue in Global (2018-2023)
7.8.5 Bio Kangtai Key News & Latest Developments
8 Global Pneumococcal Vaccination Production Capacity, Analysis
8.1 Global Pneumococcal Vaccination Production Capacity, 2018-2029
8.2 Pneumococcal Vaccination Production Capacity of Key Manufacturers in Global Market
8.3 Global Pneumococcal Vaccination Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pneumococcal Vaccination Supply Chain Analysis
10.1 Pneumococcal Vaccination Industry Value Chain
10.2 Pneumococcal Vaccination Upstream Market
10.3 Pneumococcal Vaccination Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pneumococcal Vaccination Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Pneumococcal Vaccination in Global Market
Table 2. Top Pneumococcal Vaccination Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Pneumococcal Vaccination Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Pneumococcal Vaccination Revenue Share by Companies, 2018-2023
Table 5. Global Pneumococcal Vaccination Sales by Companies, (Units), 2018-2023
Table 6. Global Pneumococcal Vaccination Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Pneumococcal Vaccination Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Pneumococcal Vaccination Product Type
Table 9. List of Global Tier 1 Pneumococcal Vaccination Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pneumococcal Vaccination Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Pneumococcal Vaccination Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Pneumococcal Vaccination Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Pneumococcal Vaccination Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Pneumococcal Vaccination Sales (Units), 2018-2023
Table 15. By Type - Global Pneumococcal Vaccination Sales (Units), 2024-2029
Table 16. By Application – Global Pneumococcal Vaccination Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Pneumococcal Vaccination Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Pneumococcal Vaccination Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Pneumococcal Vaccination Sales (Units), 2018-2023
Table 20. By Application - Global Pneumococcal Vaccination Sales (Units), 2024-2029
Table 21. By Region – Global Pneumococcal Vaccination Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Pneumococcal Vaccination Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Pneumococcal Vaccination Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Pneumococcal Vaccination Sales (Units), 2018-2023
Table 25. By Region - Global Pneumococcal Vaccination Sales (Units), 2024-2029
Table 26. By Country - North America Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Pneumococcal Vaccination Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Pneumococcal Vaccination Sales, (Units), 2018-2023
Table 29. By Country - North America Pneumococcal Vaccination Sales, (Units), 2024-2029
Table 30. By Country - Europe Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Pneumococcal Vaccination Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Pneumococcal Vaccination Sales, (Units), 2018-2023
Table 33. By Country - Europe Pneumococcal Vaccination Sales, (Units), 2024-2029
Table 34. By Region - Asia Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Pneumococcal Vaccination Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Pneumococcal Vaccination Sales, (Units), 2018-2023
Table 37. By Region - Asia Pneumococcal Vaccination Sales, (Units), 2024-2029
Table 38. By Country - South America Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Pneumococcal Vaccination Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Pneumococcal Vaccination Sales, (Units), 2018-2023
Table 41. By Country - South America Pneumococcal Vaccination Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Pneumococcal Vaccination Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Pneumococcal Vaccination Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Pneumococcal Vaccination Sales, (Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Pneumococcal Vaccination Product Offerings
Table 48. Pfizer Pneumococcal Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Pneumococcal Vaccination Product Offerings
Table 52. GSK Pneumococcal Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. MSD Company Summary
Table 55. MSD Pneumococcal Vaccination Product Offerings
Table 56. MSD Pneumococcal Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. MSD Key News & Latest Developments
Table 58. Sanofipasteur Company Summary
Table 59. Sanofipasteur Pneumococcal Vaccination Product Offerings
Table 60. Sanofipasteur Pneumococcal Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sanofipasteur Key News & Latest Developments
Table 62. CDIBP Company Summary
Table 63. CDIBP Pneumococcal Vaccination Product Offerings
Table 64. CDIBP Pneumococcal Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. CDIBP Key News & Latest Developments
Table 66. WALVAX Company Summary
Table 67. WALVAX Pneumococcal Vaccination Product Offerings
Table 68. WALVAX Pneumococcal Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. WALVAX Key News & Latest Developments
Table 70. Sinovac Company Summary
Table 71. Sinovac Pneumococcal Vaccination Product Offerings
Table 72. Sinovac Pneumococcal Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Sinovac Key News & Latest Developments
Table 74. Bio Kangtai Company Summary
Table 75. Bio Kangtai Pneumococcal Vaccination Product Offerings
Table 76. Bio Kangtai Pneumococcal Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Bio Kangtai Key News & Latest Developments
Table 78. Pneumococcal Vaccination Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 79. Global Pneumococcal Vaccination Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Pneumococcal Vaccination Production by Region, 2018-2023 (Units)
Table 81. Global Pneumococcal Vaccination Production by Region, 2024-2029 (Units)
Table 82. Pneumococcal Vaccination Market Opportunities & Trends in Global Market
Table 83. Pneumococcal Vaccination Market Drivers in Global Market
Table 84. Pneumococcal Vaccination Market Restraints in Global Market
Table 85. Pneumococcal Vaccination Raw Materials
Table 86. Pneumococcal Vaccination Raw Materials Suppliers in Global Market
Table 87. Typical Pneumococcal Vaccination Downstream
Table 88. Pneumococcal Vaccination Downstream Clients in Global Market
Table 89. Pneumococcal Vaccination Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pneumococcal Vaccination Segment by Type in 2022
Figure 2. Pneumococcal Vaccination Segment by Application in 2022
Figure 3. Global Pneumococcal Vaccination Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pneumococcal Vaccination Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pneumococcal Vaccination Revenue, 2018-2029 (US$, Mn)
Figure 7. Pneumococcal Vaccination Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Pneumococcal Vaccination Revenue in 2022
Figure 9. By Type - Global Pneumococcal Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Pneumococcal Vaccination Revenue Market Share, 2018-2029
Figure 11. By Type - Global Pneumococcal Vaccination Sales Market Share, 2018-2029
Figure 12. By Type - Global Pneumococcal Vaccination Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Pneumococcal Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Pneumococcal Vaccination Revenue Market Share, 2018-2029
Figure 15. By Application - Global Pneumococcal Vaccination Sales Market Share, 2018-2029
Figure 16. By Application - Global Pneumococcal Vaccination Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Pneumococcal Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Pneumococcal Vaccination Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Pneumococcal Vaccination Revenue Market Share, 2018-2029
Figure 20. By Region - Global Pneumococcal Vaccination Sales Market Share, 2018-2029
Figure 21. By Country - North America Pneumococcal Vaccination Revenue Market Share, 2018-2029
Figure 22. By Country - North America Pneumococcal Vaccination Sales Market Share, 2018-2029
Figure 23. US Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Pneumococcal Vaccination Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Pneumococcal Vaccination Sales Market Share, 2018-2029
Figure 28. Germany Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 29. France Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Pneumococcal Vaccination Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Pneumococcal Vaccination Sales Market Share, 2018-2029
Figure 37. China Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 41. India Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Pneumococcal Vaccination Revenue Market Share, 2018-2029
Figure 43. By Country - South America Pneumococcal Vaccination Sales Market Share, 2018-2029
Figure 44. Brazil Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Pneumococcal Vaccination Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Pneumococcal Vaccination Sales Market Share, 2018-2029
Figure 48. Turkey Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Pneumococcal Vaccination Revenue, (US$, Mn), 2018-2029
Figure 52. Global Pneumococcal Vaccination Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Pneumococcal Vaccination by Region, 2022 VS 2029
Figure 54. Pneumococcal Vaccination Industry Value Chain
Figure 55. Marketing Channels

※参考情報

肺炎球菌ワクチン接種についての概念は、肺炎球菌による感染症からの感染予防を目的とした医療行為の一つです。肺炎球菌はストレプトコッカス・ニューモニエ（Streptococcus pneumoniae）という細菌であり、主に肺炎や髄膜炎、耳炎、血流感染などの原因となります。この細菌による感染症は特に乳幼児、高齢者、免疫機能が低下している人々にとって重篤な病状を引き起こすことがあります。そのため、ワクチン接種による予防が重要視されています。

肺炎球菌ワクチン接種の特徴として、まず、これらのワクチンは主に肺炎球菌の表面抗原に基づいており、免疫系が具体的な病原体を認識し、今後の感染に対して防御するための抗体を生成することを促進します。肺炎球菌には多くの血清型が存在し、これに対して開発されたワクチンは、これらの血清型に対する保護を提供することを目的としています。

肺炎球菌ワクチンには主に二つの大きな種類があります。ひとつはポリサッカライドワクチンで、もうひとつは結合ワクチンです。ポリサッカライドワクチンは、肺炎球菌の多糖体を基にしており、成人や高齢者に一般的に用いられます。このワクチンは特定の血清型に対する免疫を提供しますが、乳幼児に対しては効果が限られています。一方、結合ワクチンは、ポリサッカライド抗原をタンパク質と結合させたもので、特に小さな子どもたちに対しても適用可能です。結合ワクチンは免疫応答を強化し、より広範囲な感染予防に寄与します。

肺炎球菌ワクチン接種の用途は、主に肺炎球菌による感染症の予防ですが、特にリスクが高い集団に対してはさらに重要な役割を果たします。例えば、65歳以上の高齢者、慢性疾患を持つ人々（糖尿病、心疾患、呼吸器疾患など）、免疫抑制状態にある人々は、肺炎球菌による感染のリスクが高く、これらの人々におけるワクチン接種は特に推奨されています。また、保育園や学校などの集団生活を送る子どもたちの間でも、感染拡大を防ぐための接種が重要です。

関連技術としては、ワクチンの製造過程や保存方法、接種の手法などが挙げられます。肺炎球菌ワクチンは、製造時に厳密な管理が行われており、品質を保持するために冷蔵保存条件が必要です。また、接種方法も重要で、通常は筋肉内接種が行われますが、高齢者や特定の条件を持つ患者に対しては皮下接種が選択される場合もあります。

さらに、肺炎球菌ワクチンの効果を高めるために、他のワクチンとの同時接種が推奨されることもあります。例えば、インフルエンザワクチンや百日咳ワクチンと一緒に接種することで、総合的な防御力を強化することができます。また、今後の研究においては、肺炎球菌に対する新しいワクチン技術の開発も進められており、より広範囲にわたる血清型への対応や、免疫応答の向上に向けた取り組みも行われています。

肺炎球菌ワクチン接種を受けることで得られる利点は数多くあります。特に、高齢者や免疫抑制状態の人々においては、重篤な合併症を防ぎ、入院や死亡リスクを大幅に低減することが助けられています。さらに、ワクチン接種は集団免疫の形成にも寄与し、社会全体での感染症の蔓延を防ぐことにもつながります。

ただし、ワクチン接種には副反応が伴うこともあるため、接種を考える際には医療機関での相談が重要です。一般的な副反応には、接種部位の疼痛、発熱、倦怠感などがありますが、重篤な副反応は稀です。これらのリスクとワクチンによる利益を天秤にかけながら、接種を決断することが求められます。

まとめると、肺炎球菌ワクチン接種は肺炎球菌による感染症からの予防において極めて重要な手段であり、特に高齢者やリスク群の人々における接種が推奨されています。多様な種類のワクチンの存在、関連技術の発展、及び感染症予防のための有効な手段としての役割があり、今後も研究や開発が続けられていくことでしょう。ワクチン接種を通じて、個人の健康を守るだけでなく、社会全体の健康も支えていくことが求められます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 肺炎球菌ワクチン接種の世界市場見通し2023年-2029年(Pneumococcal Vaccination Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

肺炎球菌ワクチン接種の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp